| Aktie | Ticker | 2025/Q4 | ||
|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | ||
| 114.419.671 $ | +114.419.671 $ | |||
| BANK OF AMERICA CORP /DE/ | BAC | 105.421.612 $ | +105.421.612 $ | |
| Jazz Pharmaceuticals plc | JAZZ | 553.860 $ | +553.860 $ | |
| Ascendis Pharma A/S | ASND | 549.946 $ | +549.946 $ | |
| Centessa Pharmaceuticals plc | CNTA | 547.194 $ | +547.194 $ | |
| IONIS PHARMACEUTICALS INC | IONS | 537.948 $ | +537.948 $ | |
| Royalty Pharma plc | RPRX | 534.237 $ | +534.237 $ | |
| INSMED Inc | INSM | 530.648 $ | +530.648 $ | |
| Legend Biotech Corp | LEGN | 530.391 $ | +530.391 $ | |
| ARGENX SE | ARGX | 529.799 $ | +529.799 $ | |
| NEUROCRINE BIOSCIENCES INC | NBIX | 529.593 $ | +529.593 $ | |
| INCYTE CORP | INCY | 528.420 $ | +528.420 $ | |
| CYTOKINETICS INC | CYTK | 528.208 $ | +528.208 $ | |
| ACADIA PHARMACEUTICALS INC | ACAD | 527.950 $ | +527.950 $ | |
| UNITED THERAPEUTICS Corp | UTHR | 526.230 $ | +526.230 $ | |
| BIOMARIN PHARMACEUTICAL INC | BMRN | 521.320 $ | +521.320 $ | |
| Syndax Pharmaceuticals Inc | SNDX | 519.283 $ | +519.283 $ | |
| CRISPR Therapeutics AG | CRSP | 502.375 $ | +502.375 $ | |
| Immunocore Holdings plc | IMCR | 500.657 $ | +500.657 $ | |
| 114.419.671 $ | +114.419.671 $ | |||